For instance, in a recent preclinical study using a mouse model of prostate cancer which responded poorly to immune checkpoint inhibition, the therapy became effective when application of the anti-PD-1 or anti-PD-L1 antibodies was coupled with irradiation of the tumor graft at high doses of X-rays [59]. Here, CD274 is linked to prostate cancer.